Prediction of prostate carcinoma stage by quantitative biopsy pathology
β Scribed by Robert W. Veltri; M. Craig Miller; Alan W. Partin; Edward C. Poole; Gerard J. O'Dowd
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 95 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Stage is a significant predictor of outcome for patients with carcinoma of the prostate. The American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) TNM staging system has gained general favor as the clinical staging system of choice for prostate
BACKGROUND. A Nomogram based on pretreatment prostate specific antigen (
## BACKGROUND. Information regarding the quantity of biopsy material invaded by cancer may supplement the usual criteria for the preoperative staging of patients suffering from clinically localized prostate carcinoma (T1 -T2). However, conflicting conclusions have been drawn and this topic needs f
The authors thank Ms. Nebahat Gu Β¨rses and Ms. Sylvia Schno Β¨ger for their expert help in performing the in situ hybridizations.
## BACKGROUND. The aim of this study was to identify better prognostic parameters for normalization of serum calcitonin in medullary thyroid carcinoma (MTC) patients. ## METHODS. In 73 patients who had undergone systematic lymph node dissection for MTC between September 1995 and November 1998, pr